首页> 外文期刊>The Open Biochemistry Journal >In the Huh7 Hepatoma Cells Diclofenac and Indomethacin Activate Differently the Unfolded Protein Response and Induce ER Stress Apoptosis
【24h】

In the Huh7 Hepatoma Cells Diclofenac and Indomethacin Activate Differently the Unfolded Protein Response and Induce ER Stress Apoptosis

机译:在Huh7肝癌细胞中,双氯芬酸和消炎痛激活的蛋白质反应不同,并诱导ER应激凋亡。

获取原文
           

摘要

Non-steroidal anti-inflammatory drugs (NSAIDs) are cyclooxygenases (COXs) inhibitors frequently used in the treatment of acute and chronic inflammation. Side effects of NSAIDs are often due to their ability to induce apoptosis. Located at the Endoplasmic Reticulum membranes a tripartite signalling pathway, collectively known as the Unfolded Protein Response (UPR), decides survival or death of cells exposed to cytotoxic agents. To shed light on the molecular events responsible for the cytotoxicity of NSAIDs, we analysed the ability of diclofenac and indomethacin to activate the UPR in the human hepatoma cell line Huh7. We report that both NSAIDs can induce differently the single arms of the UPR. We show that indomethacin turns on the PERK and, only in part, the ATF6 and IRE1 pathways. Instead, diclofenac reduces the expression of ATF6 and does not stimulate the IRE1 endonuclease, which drives the expression of the prosurvival factor XBP1. Diclofenac, as well as indomethacin, is able to activate efficiently only the PERK pathway of the UPR, which induces the expression of the proapoptotic GADD153/CHOP protein. Our results highlight the importance of the UPR in evaluating the potential of drugs to induce apoptosis.
机译:非甾体类抗炎药(NSAIDs)是环氧合酶(COXs)抑制剂,常用于治疗急性和慢性炎症。非甾体抗炎药的副作用通常归因于其诱导凋亡的能力。位于内质网膜上的三方信号通路(统称为“未折叠蛋白反应”(UPR))决定了暴露于细胞毒剂的细胞的存活或死亡。为了阐明负责NSAIDs细胞毒性的分子事件,我们分析了双氯芬酸和消炎痛激活人类肝癌细胞系Huh7中的UPR的能力。我们报告说,两种NSAIDs都可以不同地诱导普遍定期审议的单一方面。我们显示吲哚美辛打开PERK,并且仅部分打开ATF6和IRE1通路。相反,双氯芬酸会降低ATF6的表达,并且不会刺激IRE1核酸内切酶,而IRE1核酸内切酶会驱动生存因子XBP1的表达。双氯芬酸以及吲哚美辛能够仅有效激活UPR的PERK途径,从而诱导促凋亡的GADD153 / CHOP蛋白表达。我们的结果强调了UPR在评估药物诱导凋亡的潜力中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号